This talk will focus on polymer conjugates and polymeric nanoparticles to enhance the drug delivery of protein therapeutics for the treatment of diabetes. The rational design, synthesis, and preclinical evaluation of these materials will be discussed. Materials that respond to chemical triggers in vivo and reductive pH will be disclosed with a focus on therapeutics for diabetes. Polymers that contain groups that actively stabilize these therapeutics will also be revealed.

Responsive nanomaterials for delivery of diabetes medicines will be discussed. Image created by Ellie Puente (UCLA).

Responsive nanomaterials for delivery of diabetes medicines will be discussed. Image created by Ellie Puente (UCLA).

Heather Maynard

Appearances